performed a cross-trial analysis using data from clinical trials of GLP-1RAs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER-6 [59], and AMPLITUDE-O), SGLT2is (CANVAS and CREDENCE), and finerenone (FIDELIO-DKD and FIGARO-DKD) to estimate the effects of the triple combination therapy of GLP-1RA, SGLT2i, and finerenone using the actuarial method [60]
Vargas, J
Given his results, while I might try just high dose serine first, adding NAC, nicotinamide riboside, glycine and carnitine also makes sense, as Mardinoglus research suggests
As of July 1, 2025, many Aetna standard commercial plans removed Zepbound from their formularies when prescribed for the purpose of weight management